| Financial Year |
March 31 2023 |
| Monetary Funds |
5,031,938,968.80 |
| Held-for-trading Financial Assets |
300,087,805.56 |
| Notes Receivable |
47,478,538.54 |
| Accounts Receivable |
5,854,592,124.93 |
| Advances to Suppliers |
610,306,399.12 |
| Other Receivables |
150,234,731.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,713,218,168.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,514,914.38 |
| Total Current Assets |
23,090,463,677.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
40,059,288.00 |
| Long-term Equity Investment |
2,837,335,936.94 |
| Investment Properties |
300,434,073.70 |
| Fixed Assetes |
9,852,654,182.83 |
| Under-construction Projects |
1,459,818,719.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,593,823,277.65 |
| R&D expenses |
-- |
| Goodwill |
17,404,465.56 |
| Long-Term Deferred and Prepaid Expenses |
155,902,132.79 |
| Deferred Income Tax Assets |
786,455,658.47 |
| Other Non-Current Assets |
251,441,173.96 |
| Sub-Total of Non-Current Assets |
17,392,923,511.23 |
| Total Assets |
40,483,387,189.00 |
| Short-Term Loans |
3,009,862,792.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,456,859,149.77 |
| Accounts Payable |
3,423,601,142.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
183,540,971.79 |
| Taxes Payable |
272,859,678.43 |
| Interest Payable |
-- |
| Dividend Payable |
236,165,413.68 |
| Other payables |
750,693,705.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,949,897,712.93 |
| Other Current Liabilities |
980,246,539.33 |
| Sub-Total of Current Liabilities |
12,483,919,804.90 |
| Long-term Loans |
7,225,107,647.51 |
| Bonds Payable |
2,236,660,309.46 |
| Long-Term Accounts Payable |
121,202,577.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,419,069.21 |
| Deferred Income Tax Liabilities |
43,489,184.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,044,278,301.92 |
| Total Liabilities |
22,528,198,106.82 |
| Paid-In Capital(Or Share Stock) |
1,418,459,200.00 |
| Capital Surplus |
3,299,292,816.44 |
| Surplus Reserve |
534,043,080.11 |
| LESS:Treasury Stock |
50,098,868.00 |
| Undistributed Profits |
5,130,156,919.83 |
| Minority Stockholder's Interest |
7,498,288,647.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,456,900,434.86 |
| Owner's Equity（Stockholder's Equity） |
17,955,189,082.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,483,387,189.00 |
